National Feb 3, 2021
BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand
Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.
BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand
Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.
The request comes after Berlin asked for the island's assistance in easing a shortage of automobile semiconductor chips.
Pfizer shot only slightly less effective against key South African mutations, study says
Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to only lose a small bit of effectiveness against an engineered virus with three key mutations from the new variant found in South Africa, according to a laboratory study conducted by the U.S. drugmaker. The study by Pfizer ...
mRNA vaccines could vanquish COVID-19 today, cancer tomorrow
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.